Authors: Aleeva M.M., Shevkolenko M.V., Clinical Ophthalmologic Hospital “Center for Eye Microsurgery”, Kyiv, Ukraine
Objective
To study the clinical efficacy of an integrated approach in the treatment of refractive amblyopia in mixed astigmatism.
Conclusions
Thus, the results of the study demonstrated the advantages of an integrated approach in the treatment of refractive amblyopia in mixed astigmatism, which is due to the modern progressive design of the soft contact lenses and the neuroprotective properties of lutein and other components that make up the drug “Slezavit”.
VI Scientific and Practical Conference of Pediatric Ophthalmologists of Ukraine with International Participation ‘2015
